 |
|
|
|
|
|
|
|
|
|
Roche continues to believe its Genentech proposal is fair and generous.
Basel, 14 August 2008
The special committee of the Board of Directors of Genentech announced that it believes that Roche's proposal to acquire the shares of Genentech not owned by Roche for $89.00 per share substantially undervalues the company. However, the special committee said it would consider a proposal that recognizes the value of the company and reflects the significant benefits that would accrue to Roche as a result of full ownership. Roche continues to believe its proposal is fair and generous. |
|
|
|
|
|
|
|
|
|
